World's Best Scientists 2026 revealed!
Umberto Spampinato

Umberto Spampinato

D-Index & Metrics

Neuroscience

D-Index
52
Citations
7716
World Ranking
5404
National Ranking
230

Umberto Spampinato publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Umberto Spampinato sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 109 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Umberto Spampinato D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Umberto Spampinato sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 52 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Umberto Spampinato is affiliated with the University of Bordeaux in France. Their research primarily spans the fields of Medicine, Neuroscience, and Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Cellular and Molecular Neuroscience, Neurology, Molecular Biology, Pharmacology, and Epidemiology.

The main topics addressed in Spampinato's body of work include:

  • Neurotransmitter Receptor Influence on Behavior
  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology

Spampinato's recent publications demonstrate a focus on receptor signaling and neuropsychiatric conditions, highlighting contributions such as:

  • "Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials" (2023), published in Nature Medicine
  • "The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism" (2020), published in Movement Disorders Clinical Practice
  • "Brain 5-HT1A Receptor Binding in Multiple System Atrophy: An [18F]-MPPF PET Study" (2020), published in Movement Disorders
  • "Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways" (2020), published in Neuropharmacology
  • "Differential expression of serotonin2B receptors in GABAergic and serotoninergic neurons of the rat and mouse dorsal raphe nucleus" (2022), published in Molecular and Cellular Neuroscience

Frequent collaborators in Spampinato's work include:

  • Adeline Cathala
  • Wassilios G. Meissner
  • Olivier Rascol
  • Jean-Michel Revest
  • Ana Marquès

The distinct publication venues where Spampinato often contributes are:

  • Movement Disorders
  • Nature Medicine
  • Movement Disorders Clinical Practice
  • Neuropharmacology
  • Molecular and Cellular Neuroscience

Best Publications

  • Novel pharmacological targets for the treatment of Parkinson's disease

    Anthony H V Schapira;Erwan Bezard;Jonathan Brotchie;Frédéric Calon

  • Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

    Philippe De Deurwaerdère;Sylvia Navailles;Kelly A. Berg;William P. Clarke

  • Pregnenolone Can Protect the Brain from Cannabis Intoxication

    Monique Vallée;Monique Vallée;Sergio Vitiello;Sergio Vitiello;Luigi Bellocchio;Luigi Bellocchio;Etienne Hébert-Chatelain;Etienne Hébert-Chatelain

  • Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

    Davina J Hensman Moss;Antonio F Pardiñas;Douglas Langbehn;Kitty Lo

  • 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

    Grégory Porras;Vincenzo Di Matteo;Claudia Fracasso;Guillaume Lucas

  • Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.

    G Di Giovanni;P De Deurwaerdére;M Di Mascio;V Di Matteo

  • Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.

    Guillaume Lucas;Umberto Spampinato

  • In vivo release of [3H]γ-aminobutyric acid in the rat neostriatum—II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen

    J.A. Girault;U. Spampinato;J. Glowinski;M.J. Besson

  • Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain?

    M. Hamon;J-M. Cossery;U. Spampinato;H. Gozlan

  • Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain.

    H. Gozlan;G. Daval;D. Verge;U. Spampinato

  • Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development

    G. Daval;D. Vergé;A. Becerril;H. Gozlan

  • Role of Serotonin2A and Serotonin2B/2C Receptor Subtypes in the Control of Accumbal and Striatal Dopamine Release Elicited In Vivo by Dorsal Raphe Nucleus Electrical Stimulation

    Philippe De Deurwaerdère;Umberto Spampinato

  • Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors

    Philippe De Deurwaerdère;Luis Stinus;Umberto Spampinato

  • In Vivo Release of Endogenous Amino Acids from the Rat Striatum: Further Evidence for a Role of Glutamate and Aspartate in Corticostriatal Neurotransmission

    Jean Antoine Girault;Luis Barbeito;Umberto Spampinato;Henri Gozlan

  • Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.

    N. Bonhomme;P. De Deurwaèrdere;M. Le Moal;U. Spampinato

  • Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors

    Kelly A. Berg;John A. Harvey;Umberto Spampinato;William P. Clarke

  • Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine.

    Sylvia Navailles;Delphine Moison;Kathryn A Cunningham;Umberto Spampinato

  • Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.

    V.J. Aloyo;K.A. Berg;U. Spampinato;W.P. Clarke

  • 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

    Guillaume Lucas;Norbert Bonhomme;Philippe De Deurwaerdère;Michel Le Moal

  • In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.

    Sylvia Navailles;Philippe De Deurwaerdère;Grégory Porras;Umberto Spampinato

  • Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

    Kelly A. Berg;William P. Clarke;Kathryn A. Cunningham;Umberto Spampinato

Frequent Co-Authors

Philippe De Deurwaerdère
Philippe De Deurwaerdère University of Bordeaux
François Tison
François Tison University of Bordeaux
Olivier Rascol
Olivier Rascol Federal University of Toulouse Midi-Pyrénées
Jacques Glowinski
Jacques Glowinski Collège de France
Filippo Drago
Filippo Drago University of Catania
Jean-Louis Montastruc
Jean-Louis Montastruc Grenoble Alpes University
Francesc Artigas
Francesc Artigas Spanish National Research Council
Giovanni Marsicano
Giovanni Marsicano University of Bordeaux

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Umberto Spampinato

Trending Scientists